340 related articles for article (PubMed ID: 3062325)
21. Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes.
Shimada T; Nakamura S; Imaoka S; Funae Y
Toxicol Appl Pharmacol; 1987 Oct; 91(1):13-21. PubMed ID: 3118508
[TBL] [Abstract][Full Text] [Related]
22. Metabolic activation of 2-amino-9H-pyrido[2,3-b]indole by rat-liver microsomes.
Niwa T; Yamazoe Y; Kato R
Mutat Res; 1982 Aug; 95(2-3):159-70. PubMed ID: 6750381
[TBL] [Abstract][Full Text] [Related]
23. Non-mutagenicity of 27 aliphatic acrylate esters in the Salmonella-microsome test.
Waegemaekers TH; Bensink MP
Mutat Res; 1984; 137(2-3):95-102. PubMed ID: 6381999
[TBL] [Abstract][Full Text] [Related]
24. Absence of mutagenic activity of benorylate, paracetamol and aspirin in the Salmonella/mammalian microsome test.
Jasiewicz ML; Richardson JC
Mutat Res; 1987 Feb; 190(2):95-100. PubMed ID: 2881204
[TBL] [Abstract][Full Text] [Related]
25. Mutagenicity of diphenylhydantoin and some of its metabolites towards salmonella typhimurium strains.
Sezzano P; Raimondi A; Arboix M; Pantarotto C
Mutat Res; 1982 Mar; 103(3-6):219-28. PubMed ID: 7045642
[TBL] [Abstract][Full Text] [Related]
26. [Mutagenicity of mixtures of halogenated aliphatic hydrocarbons and polycyclic aromatic hydrocarbons in the Ames test with TA98 and TA100].
Kevekordes S; Porzig J; Gebel T; Dunkelberg H
Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):531-41. PubMed ID: 9531725
[TBL] [Abstract][Full Text] [Related]
27. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
[TBL] [Abstract][Full Text] [Related]
28. Interaction with microsomal lipid as a major factor responsible for S9-mediated inhibition of 1,8-dinitropyrene mutagenicity.
Shah AB; Combes RD; Rowland IR
Mutat Res; 1991 Jul; 249(1):93-104. PubMed ID: 2067546
[TBL] [Abstract][Full Text] [Related]
29. The metabolic activation of benzo(a)pyrene and 9-hydroxybenzo(a)pyrene by liver microsomal fractions.
Lubet RA; Capdevila J; Prough RA
Int J Cancer; 1979 Mar; 23(3):353-7. PubMed ID: 374283
[TBL] [Abstract][Full Text] [Related]
30. Mutagenic evaluation of the monocyclic aromatic amine N-methylamino-2-nitro-4-N', N'-bis(2-hydroxyethyl)-aminobenzene in the Salmonella typhimurium/mammalian microsome test.
Shahin MM; Bugaut A
Mutat Res; 1983 Feb; 116(2):155-9. PubMed ID: 6338359
[TBL] [Abstract][Full Text] [Related]
31. Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay.
Anderson JG; McCalla DR; Bryant DW; McCarry BE; Bromke AM
Mutagenesis; 1987 Jul; 2(4):279-85. PubMed ID: 3325759
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of beta-naphthoxyacetic acid for mutagenic activity in the Salmonella/mammalian microsome assay.
Rashid KA; Mumma RO
J Environ Sci Health B; 1986 Jun; 21(3):243-50. PubMed ID: 3528271
[TBL] [Abstract][Full Text] [Related]
33. Mutagenicity of 2-methylacrolein, 2-ethylacrolein and 2-propylacrolein in Salmonella typhimurium TA100. A comparative study.
Neudecker T; Eder E; Deininger C; Henschler D
Mutat Res; 1991 Dec; 264(4):193-6. PubMed ID: 1723498
[TBL] [Abstract][Full Text] [Related]
34. The mutagenicity of dinitrotoluenes in Salmonella typhimurium.
Couch DB; Allen PF; Abernethy DJ
Mutat Res; 1981 Dec; 90(4):373-83. PubMed ID: 7038460
[TBL] [Abstract][Full Text] [Related]
35. The hepatic conversion of some heterocyclic amines to bacterial mutagens is modified by dietary fat and cholesterol.
Alldrick AJ; Rowland IR; Wise A
Mutagenesis; 1987 May; 2(3):221-4. PubMed ID: 3325747
[TBL] [Abstract][Full Text] [Related]
36. Furoquinoline alkaloids as photosensitizers in Chlamydomonas reinhardtii.
Schimmer O; Kühne I
Mutat Res; 1991 Jul; 249(1):105-10. PubMed ID: 2067526
[TBL] [Abstract][Full Text] [Related]
37. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
Araki A; Kamigaito N; Sasaki T; Matsushima T
Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
[TBL] [Abstract][Full Text] [Related]
38. Effect of liver enzyme inducers on metabolite excretion in rats treated with 1-nitropyrene.
Belisario MA; Carrano L; De Giulio A; Pecce R; Buonocore V
Toxicol Lett; 1987 May; 36(3):233-41. PubMed ID: 3296319
[TBL] [Abstract][Full Text] [Related]
39. Activation of phenanthrene to mutagenic metabolites and evidence for at least two different activation pathways.
Oesch F; Bücker M; Glatt HR
Mutat Res; 1981 Mar; 81(1):1-10. PubMed ID: 7019683
[TBL] [Abstract][Full Text] [Related]
40. The Salmonella mutagenicity test: evaluation of 29 drug candidates.
Aaron CS; Mazurek J; Zimmer DM; Swenson DH
Mutat Res; 1989 Jun; 223(2):171-82. PubMed ID: 2662001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
